REGENXBIO, Inc. (RGNX)

9.14 +0.45 (+5.18%) USD  |  NASDAQ  |  Mar 04, 16:00
8.86 -0.28 (-3.06%) Pre-Market: 09:08
More

REGENXBIO Other Income and Expenses (Quarterly)

Other Income and Expenses (Quarterly) Chart

View Other Income and Expenses (Quarterly) for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Income and Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Income and Expenses (Quarterly) Range, Past 5 Years

View Other Income and Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Income and Expenses (Quarterly) Benchmarks

View Other Income and Expenses (Quarterly) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Omeros Corp. --
Ultragenyx Pharmaceutical, Inc. Upgrade
CytomX Therapeutics, Inc. Upgrade